The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology
Open accessAbstract
In addition to amyloid-β plaque and tau neurofibrillary tangle deposition, neuroinflammation is considered a key feature of Alzheimer’s disease pathology. Inflammation in Alzheimer's disease is characterized by the presence of reactive astrocytes and activated microglia surrounding amyloid plaques, implicating their role in disease pathogenesis. Microglia in the healthy adult mouse depend on colony-stimulating factor 1 receptor (CSF1R) signalling for survival, and pharmacological inhibition of this receptor results in rapid elimination of nearly all of the microglia in the central nervous system. In this study, we set out to determine if chronically activated microglia in the Alzheimer's disease brain are also dependent on CSF1R signalling, and if so, how these cells contribute to disease pathogenesis. Ten-month-old 5xfAD mice were treated with a selective CSF1R inhibitor for 1 month, resulting in the elimination of ∼80% of microglia. Chronic microglial elimination does not alter amyloid-β levels or plaque load; however, it does rescue dendritic spine loss and prevent neuronal loss in 5xfAD mice, as well as reduce overall neuroinflammation. Importantly, behavioural testing revealed improvements in contextual memory. Collectively, these results demonstrate that microglia contribute to neuronal loss, as well as memory impairments in 5xfAD mice, but do not mediate or protect from amyloid pathology. Microglia-mediated inflammation is a driving force in Alzheimer’s disease pathogenesis. Spangenberg et al . show that elimination of microglia in 5xfAD mice improves cognitive function and ameliorates synaptic/neuronal loss without altering amyloid-β levels or plaque load. Thus, microglia act downstream of plaques to mediate damage to the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In mice that serve as a model for Alzheimer’s disease, microglia depletion was generally beneficial by decreasing plaque formation (26).”
From Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection (2020) · cites this paper as [26]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mouse models of AD genetic or pharmacological depletion of microglia prevented microglia association with amyloid plaques and neuronal loss, which led to improved learning and memory without affecting amyloid plaque load in mouse brain (Dagher et al., 2015; Rice et al., 2015; Spangenberg et al., 2016).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Spangenberg et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“microglia depletion before or after the formation of Aβ pathology in mouse models of AD resulted in improved contextual memory”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the use of these agents is limited in experimental TBI studies, several groups have reported that microglial elimination [via colony-stimulating factor 1 receptor (CSF1R) inhibition] improves behavioral performance and synaptic functioning independent of Aβ accumulation in multiple transgenic mouse models of AD (3xTg, 5xFAD, APP/PS1) (236–238).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [236]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Ablation of microglia in younger mice before development of cerebral amyloidosis thus reduces Aβ deposition [294], while ablation of microglia later in disease (i.e., in 10-month-old 5xFAD mice) [296], does not alter Aβ load.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“suggesting that these cells are dispensable for Aβ clearance and plaque formation in the late stage of disease [296]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“microglia ablation in AD mouse models at 10 months of age had no impact on plaque burden”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“further implicating microglia in neuronal and/or synaptic loss [294–296]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
In the citing paper
“Unlike with synapse loss, the formation and maintenance of β-amyloid plaques in amyloidosis models does not seem to be affected by CSF1R inhibition or other methods of microglia depletion (Grathwohl et al., 2009; Olmos-Alonso et al., 2016; Spangenberg et al., 2016).”
From Microglia in Alzheimer’s disease (2018) · cites this paper as Spangenberg et al., 2016
In the citing paper
“For instance, synaptic loss is a key feature of AD pathogenesis mediated, at least in part, by microglia [13, 79].”
From Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain (2020) · cites this paper as [13]
In the citing paper
“We previously reported that neuronal and synaptic genes (e.g. Dlk2, Kcnq3, Nrg3, Scn1b) and related functional pathways (e.g. synaptic vesicles, glutamate receptors, neuronal membranes) were extensively and uniquely downregulated in the 7mo 5xFAD hippocampus compared to WT hippocampus and other 5xFAD brain regions [12], respectively, in addition to a loss of subiculum neurons and dendritic spines”
From Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain (2020) · cites this paper as [13]
In the citing paper
“yet the removal of the microglia at advanced stages of pathology protects against synaptic and neuronal loss10.”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [10]
In the citing paper
“The absence of microglia did not significantly alter the levels of Aβ38, Aβ40, or Aβ42, in detergent-soluble or -insoluble cortical and thalamic homogenates in either the 4- or 7- month cohorts (Fig. 5a–h), in line with multiple studies showing that CSF1R inhibition does not affect Aβ production/clearance10,27,28.”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [10]
In the citing paper
“Despite this response, however, Aβ clearance and plaque modulation/dynamics is unaffected10–12”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [10]
In the citing paper
“No statistical methods were used to predetermine sample sizes; however, our sample sizes are similar to those reported in recently published similar studies10,28.”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [10]
In the citing paper
“Consistent with a potential detrimental role of microglia, it was shown that ablation of microglia by a compound (PLX3397) that inhibits CSF1R did not reduce plaque burden, although it did protect synapses185.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [185]
In the citing paper
“However, global microglial depletion in AD mouse models resulted in a protective effect on synaptic health, independent of amyloid β [18, 19].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [18]
In the citing paper
“depleting microglia after amyloid-β pathology onset via pharmacological inhibition of colony-stimulating factor 1 receptor (CSF1R) signalling38 or by using the CD11b-HSVTK (TK) system39 for 4 weeks, does not affect total plaque burden.”
From Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight (2018) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 4×
“The 5xfAD mice represent an aggressive model of amyloid pathologies, with amyloid-b plaques first depositing from 2 months of age (Oakley et al., 2006).”
BackgroundMethodInfluentialHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Self-citationNaj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 695
Sweetat, S., Shabat, M. B., Theotokis, P., Suissa, N., Karafoulidou, E., Touloumi, O., Abu‐Fanne, R., Abramsky, O., Wolf, G., Saada, A., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.03110 · Cited by 6
Mao, J., Bao, Y., Liu, F., Ye, Q., Peng, J., Nie, J., Huang, L., Liao, Y., Xing, Y., Wu, D., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03299-x · Cited by 7
Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado–Joseph Disease
Campos, A. B., Duarte‐Silva, S., Fernandes, B., Coimbra, B., Campos, J., Monteiro‐Fernandes, D., Teixeira‐Castro, A., Ambrósio, A. F., & Maciel, P. (2022) · Cells · doi:10.3390/cells11132022 · Cited by 7
Wang, Y., & Han, B. (2022) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220726163514 · Cited by 6
Légrádi, Á., Dulka, K., Jancsó, G., & Gulya, K. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03244-3 · Cited by 6
Rationale and emerging evidence for microglial replacement in Alzheimer’s disease
Bang, J. Y., & Yoo, Y. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100265 · Cited by 6
Ahangaran, S., Pourgholaminejad, A., Nosrati, R., & Babaei, P. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115919 · Cited by 5
Ferreira, A. F. F., Santos-Silva, A. C., Muratori, B. G., & Britto, L. R. G. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1733682 · Cited by 5
Gerlikhman, L., Das, U., & Sarkar, D. K. (2023) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2023-0003 · Cited by 5
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
Kuhn, M. K., & Proctor, E. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26723 · Cited by 5
Qin, S.-J., Zeng, Q.-G., Zeng, H.-X., Zeng, H.-X., Wu, Q.-Z., Lv, Y., Dai, J., Dong, G., & Zeng, X. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2024.125601 · Cited by 6
Torok, J., Maia, P. D., Anand, C., & Raj, A. (2025) · Communications Biology · doi:10.1038/s42003-025-07575-1 · Cited by 8
Borjini, N., Fernández, M., Giardino, L., Sorokin, L. M., & Calzà, L. (2025) · Cells · doi:10.3390/cells14060414 · Cited by 5
Sharma, D., Rajbongshi, B., Isphak, T., Basumatary, S., Dutta, K., Rudrapal, M., & Goswami, A. K. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500038 · Cited by 6
Bergendorf, A. M., Park, J. H., Ball, B. K., & Brubaker, D. K. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00775-3 · Cited by 5
Paul, D., & Basavan, D. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00446-0 · Cited by 5
Rosi, S., & Feng, X. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.202940 · Cited by 5
Patterns of CSF Inflammatory Markers in Non-demented Older People: A Cluster Analysis
Peng, Y., Chen, B., Chi, L., Zhou, Q., Shi, Z., & Initiative, T. A. D. N. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.577685 · Cited by 5
p35 Hemizygous Deletion in 5xFAD Mice Increases Aβ Plaque Load in Males but Not in Females
Barrett, T., Marchalant, Y., & Park, K. H. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.017 · Cited by 5
The Amyloid-beta rich CNS environment alters myeloid cell functionality independent of their origin
Drost, N., Houtman, J., Cseresnyés, Z., Niesner, R. A., Rinnenthal, J.-L., Miller, K. R., Prokop, S., & Heppner, F. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-63989-3 · Cited by 5
Kaur, S., Zhang, X., Patel, S., Rodriguez, Y., Luther, K. J., Alghafli, G., Lang, R. M., Abrams, C. K., & Dobrowsky, R. T. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00223 · Cited by 5
Rui, X., Ding, Y., Zhang, N., Zhao, X., Seki, C., Yamasaki, T., Fujinaga, M., Zhang, M.-R., Qian, J., Ji, B., et al. (2025) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-025-00345-8 · Cited by 4
Liu, Y., Liao, P., Yan, B., Li, D., Zhang, S., Zhang, W., Jia, Z., Zhang, Z., Gao, H., Liu, Q., et al. (2025) · Aging Cell · doi:10.1111/acel.70228 · Cited by 4
Glotfelty, E. J., Coke, L. M., Hart, E. E., Rivell, C., Phan, A., Greer, B. D., Svarcbahs, R., Fielding, E., Necarsulmer, J., Fortuno, L. V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-31077-z · Cited by 4
Gao, C., Lin, Z., Chen, Y., Gan, R., Wang, K., He, X., & Han, H. (2025) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0015 · Cited by 5
Zhou, J., Wang, B. H., Yu, J., Wang, G., Cai, J., Yu, M., Chen, K., Wan, L., Liu, X., Yang, Z., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70795 · Cited by 4
Etxeberría, A., Lee, S.-H., Kuhn, J., Callow, M. G., Novikova, G., Fortin, J., Choy, M. K., Xie, L., Imperio, J., Vito, S., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.023 · Cited by 4
Ziaee, S. M., Nemati, S. H., Kataria, H., Jakova, E., Hosseini, S. M., Ghelich, P., McLeod, G. A., Tamayol, A., Yong, V. W., & Karimi‐Abdolrezaee, S. (2026) · Nature Communications · doi:10.1038/s41467-026-72639-7 · Cited by 4
Microbial neuraminidase induces TLR4-dependent long-term immune priming in the brain
Fernández‐Arjona, M. D. M., León‐Rodríguez, A., Grondona, J. M., & López-Ávalos, M. D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.945229 · Cited by 4
Molecular and Cellular Mechanisms of Neuropathic Pain in Aging
Huang, H., Wu, J., Chang, Y., Wang, H., Tian, Y., Chen, Z., Feng, J., & Wang, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00010 · Cited by 5
Hu, Y., Wang, X., Zhao, Z., Liu, M., Ren, X., Xian, X., Liu, C., & Wang, Q. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240118 · Cited by 4
Arnanz, M. A., Ferrer, M., Grande, M. T., Esteban, S. R. D. M., Ruiz‐Pérez, G., Cravatt, B. F., Mostany, R., Lobo, V. J. S.-A., Romero, J., & Martínez-Relimpio, A. M. (2024) · Glia · doi:10.1002/glia.24638 · Cited by 4
Generation of an Inducible Destabilized‐Domain Cre Mouse Line to Target Disease Associated Microglia
Henningfield, C. M., Ngo, M., Murray, K. M., Kwang, N. E., Tsourmas, K. I., Neumann, J. C., Pashkutz, Z. A., Kawauchi, S., Swarup, V., Lane, T. E., et al. (2025) · Glia · doi:10.1002/glia.70004 · Cited by 4
Self-citationBeckers, L., Stroobants, S., Verheijden, S., West, B. L., D’Hooge, R., & Baes, M. I. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.03.004 · Cited by 4
Self-citationLi, Z., Peng, M., Wang, C., Yang, J., Li, X., & Zhao, J. (2023) · Aging · doi:10.18632/aging.205095 · Cited by 4
Cheng, L., Su, Y., Zhi, K., Xie, Y., Zhang, C., & Meng, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.956029 · Cited by 4
Wu, Z., & Nakanishi, H. (2017) · Folia Pharmacologica Japonica · doi:10.1254/fpj.150.141 · Cited by 4
Freitag, K., Sterczyk, N., Schulz, J., Houtman, J., Fleck, L., Sigrist, S. J., Heppner, F. L., & Jendrach, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.27.424477 · Cited by 4
Commentary: How Do Microglia Regulate Neural Circuit Connectivity and Activity in the Adult Brain?
Liu, Y., Green, K. N., Holmes, T. C., & Xu, X. (2022) · Neuroscience Insights · doi:10.1177/26331055211071124 · Cited by 4
Self-citationKumar, A., Goyal, K., Pal, M., Upadhyay, P., Gupta, S., Koul, V., & Konar, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.25.497622 · Cited by 4
Park, S.-Y., Cha, N., Kim, S., Chae, S., Lee, W.-J., Jung, H., & Bae, H. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040180 · Cited by 3
Polu, P. R., & Mishra, S. (2025) · Journal of Neurogenetics · doi:10.1080/01677063.2025.2571127 · Cited by 3
Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis
Maes, K. J. H., & Briedé, J. J. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150032 · Cited by 4
Microglial phagoptosis in development, health, and disease
Li, Y., Chen, S., & Liu, Y. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107211 · Cited by 3
Lan, Z., Liu, H., Huang, C., Li, J. R., Dai, Z., Yuan, Y. Z., He, C., Qin, S., & Su, Z. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106170 · Cited by 4
Rodent Models of Alzheimer’s Disease
Singh, A., Ghosh, S., Singh, D. K. K., Yarlagadda, B., & Sinha, J. K. (2026) · Contemporary clinical neuroscience · doi:10.1007/978-3-032-18296-8_13 · Cited by 3
Mariani, M. M., Mojziszek, K., Curley, E., & Thornton, J. E. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.104631 · Cited by 3
Gauer, C., Battis, K., Schneider, Y., Florio, J. B., Mante, M., Kim, H. Y., Rissman, R. A., Hoffmann, A., & Winkler, J. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114706 · Cited by 3
Adaikkan, C., Islam, R., Bozzelli, P. L., Sears, M., Parro, C., Pao, P., Sun, N., Kim, T., Abdelaal, K., Sedgwick, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.27.648471 · Cited by 3
Viqueira, L., Navarro, E., Negredo, P., Bernal, J. A., Rodrı́guez-Franco, M. I., Tortosa, E., & López, M. G. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106253 · Cited by 2
Cao, P., Geng, C., Ren, X., Chu, X., Zhai, Y., Li, W., & Wu, C. (2026) · Biomaterials Science · doi:10.1039/d5bm01868d · Cited by 2
Neuroglia in traumatic brain injury: Pathophysiology and therapeutic targeting
Suk, K. (2026) · Brain Network Disorders · doi:10.1016/j.bnd.2026.03.002 · Cited by 2
Mikołajczak, K., Chmiel, J., & Leszek, J. (2026) · Cells · doi:10.3390/cells15121111 · Cited by 2
Targeting CSF1R: The development of small molecule inhibitors for cancer and other diseases
Xia, Z., Chen, Q., Feng, H., Zhang, M., Ren, M., Li, R., & Chen, C. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119088 · Cited by 2
Bai, Y., Choi, H. B., Wendt, S., Towriss, M., Lin, A. J., Groten, C. J., Cui, I., Nygaard, H. B., & MacVicar, B. A. (2026) · Glia · doi:10.1002/glia.70199 · Cited by 2
Hafeez, M. T., Gao, H., Ju, F., Qi, F., Li, T., & Zhang, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041494 · Cited by 2
The contribution of inflammation to Alzheimer's disease in Down syndrome
Martini, A. C., Kloske, C. M., Wilcock, D. M., & Head, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00016-5 · Cited by 2
Microglia: a potential target for neurological disorder
Parajuli, B., & Koizumi, S. (2023) · Folia Pharmacologica Japonica · doi:10.1254/fpj.23005 · Cited by 2
Liu, X., Chen, J., Du, Y., Tian, Q., Wang, L., Li, W., Liu, G., Tan, Q., Wang, J., & Deng, X. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148814 · Cited by 2
Lang, R. M., Chawla, R., Patel, S., Abrams, C. K., & Dobrowsky, R. T. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00464 · Cited by 2
Alzheimer model 5xfad mice and applications to dementia
Ayabe, T., & Ano, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00052-9 · Cited by 2
Khayer, N., Motamed, N., Marashi, S., & Goshadrou, F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288134 · Cited by 2
Rosi, S. (2017) · Brain Circulation · doi:10.4103/bc.bc_25_17 · Cited by 2
Glial Reactivity in Response to Neurotoxins: Relevance and Methods
Michalovicz, L. T., & O'Callaghan, J. P. (2019) · Neuromethods · doi:10.1007/978-1-4939-9228-7_4 · Cited by 2
Blank-Stein, N., Mayer, M., & Mass, E. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.08.001 · Cited by 2
Community Mediation Service: A Model for Teaching Democracy and Conflict Resolution.
Slaton, C. D. (1994) · Cited by 2
Davalos, D., Akassoglou, K., & Cardona, A. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814405-3.00041-2 · Cited by 3
Autophagy in DG engrams mediates Rac1-dependent forgetting via TLR2/4 signals in microgliaPreprint
Wang, Z., Chen, R., Lin, Q., Jiang, Y., Le, Q., Liu, X., Ma, L., & Wang, F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.26.457763 · Cited by 2
Liu, M., Zhu, L., Li, F., Shi, X., Shen, Y.-F., & Liu, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.06.579113 · Cited by 2
Sprecher, U., Dsouza, J., Marisat, M., Barasch, D., Mishra, K., Kakhlon, O., Manor, J., Anikster, Y., & Weil, M. (2024) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2024.101172 · Cited by 1
RIC-specific cytoprotective profile mediated by microglia in a mouse model of acute ischaemic stroke
Torres-Querol, C., Arqué, G., & Purroy, F. F. (2025) · Stroke and Vascular Neurology · doi:10.1136/svn-2025-004465 · Cited by 1
de Miranda, A. S., Vieira, É. L. M., Teixeira, A. L., & Bauer, M. E. (2026) · NeuroImmunoModulation · doi:10.1159/000550781 · Cited by 1
iPSC-derived microglia: Decoding roles and therapeutic opportunities in neurodegenerative diseases
Shan, D., Wang, H., Li, J., Tang, Y., Zhan, Z., Yan, C., Xu, J., & Liu, F. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111779 · Cited by 1
Nagata, W., & Ishizuka, T. (2026) · Human Cell · doi:10.1007/s13577-026-01381-5 · Cited by 1
Hurtado, J. C., Rakheja, R., Scatterty, K. R., Armstrong, E., Storvold, S., Nguyen, A. T., Fenrich, K. K., Monnier, P., & Fouad, K. (2026) · Scientific Reports · doi:10.1038/s41598-026-48842-3 · Cited by 1
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
Contactomics of Microglia and Intercellular Communication
Cserép, C., Pósfai, B., Szabadits, E., & Dénes, Á. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_8 · Cited by 1
Lu, C., Ren, J., Huang, S., Wang, M., Zhou, H., & Guo, J.-C. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70118 · Cited by 1
Hilla, A. M., & Fischer, D. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2979 · Cited by 1
How Repair-or-Dispose Decisions Under Stress Can Initiate Disease Progression
Nold, A., Batulin, D., Birkner, K., Bittner, S., & Tchumatchenko, T. (2020) · iScience · doi:10.1016/j.isci.2020.101701 · Cited by 1
Anti-neuroinflammatory activity of Shenqi Fuzheng Injection and its main active constituents
Wang, W., Zhang, Z., Deng, Y., Yang, Z., Hou, J., Long, H., Lei, M., & Wu, W. (2021) · BioScience Trends · doi:10.5582/bst.2021.01140 · Cited by 1
Panina, Y. A., Lopatina, O. L., Mosiagina, A. I., Komleva, Y. K., Morgun, A. V., Gorina, Y. V., & Хилажева, Е. Д. (2024) · Annals of Clinical and Experimental Neurology · doi:10.54101/acen.2023.4.9 · Cited by 1
Cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer’s diseasePreprint
Torok, J., Maia, P. D., Anand, C., & Raj, A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.06.548027 · Cited by 2
Cellular Underpinnings of the Selective Vulnerability of Tauopathic Insults in Alzheimer's DiseasePreprint
Torok, J., Maia, P. D., Anand, C., & Raj, A. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4687645 · Cited by 1
Lam, S. (2021) · theses.fr (ABES) · doi:10.70675/60b353ffz56fcz41a2z9e53zf0d9ac078167 · Cited by 1
vonderEmbse, A. N. (2017) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Choi, H., Choi, Y., Hwang, D. W., & Lee, D. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/522987
O papel da microglia no modelo da doença de Parkinson induzido pela 6-hidroxidopamina.
Pereira, C. P. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2019.tde-18092019-145844
Cramer, T., Gill, R., Thirouin, Z. S., Vaas, M., Sampath, S., Martineau, F., Noya, S. B., Colameo, D., Chang, P. K.-Y., Wu, P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.22.055087
Long Noncoding RNAs in Substance Use Disorders
Tian, C., & Hu, G. (2020) · RNA technologies · doi:10.1007/978-3-030-44743-4_18
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
Cramer, T. L. M., Gill, R., Thirouin, Z. S., Vaas, M., Sampath, S., Martineau, F. S., Noya, S. B., Colameo, D., Chang, P. K. ‐., Wu, P., et al. (2020) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-195965
Feng, X., Frias, E. S., Paladini, M. S., Chen, D., Boosalis, Z., Becker, M., Gupta, S., Liu, S., Gupta, N., & Rosi, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/794354
Microglia, TREM2, and Therapeutic Methods of Alzheimer’s Disease
Xu, S., Ji, Y., Sha, T., & Li, H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100203
Activation of Microglia and Macrophages in Neurodegenerative Diseases
Salamero‐Boix, A., Schulz, M., & Sevenich, L. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_2
Upregulation of Trem2 expression occurs exclusively on microglial contact with plaquesPreprint
Wood, J. I., Wong, E., Joghee, R., Balbaa, A., Vitanova, K. S., VanSchoiack, A., Phelan, S.-L. J., Launchbury, F., Desai, S., Tripathi, T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.26.477873
Patro, N., Kushwaha, S. S., & Patro, I. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_20
Jones, R. E., Hill, M., & Taylor, P. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17705.1
Neuroprotective and detrimental effects of astrocytes on amyloid plaque formation
Gan, H.-R. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i1.4295
Metadata
- Authors
- Spangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N.
- Affiliations
- University of California, Irvine (US)
- Plexxikon (United States) (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-02-26
- Volume
- 139
- Issue
- 4
- Pages
- 1265-1281
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5006229
- OpenAlex
- W2281702574
- Semantic Scholar
- 82920544f365b661b1f2e68abe91acd0c7d6f7f8
- Cited by
- 695
- References
- 88
- Citations by year
- 2026: 44 · 2025: 63 · 2024: 66 · 2023: 79 · 2022: 80 · 2021: 90 · 2020: 80 · 2019: 62 · 2018: 66 · 2017: 48 · 2016: 16
- FWCI
- 31.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Alzheimer's Association
- Glenn Foundation for Medical Research
- Plexxikon
- National Institutes of Health (UL1TR001414, AG00096, AG00538)
- National Institute on Aging (AG00096, AG 00538, P50AG016573, T32AG000096)
- National Institute of Neurological Disorders and Stroke (F31NS086409, R01NS083801)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- microglia, Alzheimer's disease, CSF1R inhibition, neuroinflammation, amyloid plaques, neuronal loss, dendritic spine loss, 5xFAD mice, contextual memory, synaptic loss
- MeSH terms
- Alzheimer Disease, Animals, Brain, Female, Male, Mice, Inbred C57BL, Mice, Transgenic, Neurons, Amyloid beta-Peptides, Microglia, Mice, Mice, 129 Strain, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
